Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X2PQ
|
|||
| Former ID |
DIB016647
|
|||
| Drug Name |
IX207-887
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Discontinued in Phase 2 | [1] | |
| Company |
Sandoz AG
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H12O3S
|
|||
| Canonical SMILES |
COC1=CC2=CC=CC=C2C(=CC(=O)O)C3=C1SC=C3
|
|||
| InChI |
1S/C16H12O3S/c1-19-14-8-10-4-2-3-5-11(10)13(9-15(17)18)12-6-7-20-16(12)14/h2-9H,1H3,(H,17,18)/b13-9-
|
|||
| InChIKey |
XIKRQPKFOKKGGW-LCYFTJDESA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002363) | |||
| REF 2 | Inhibition of interleukin-1 release by IX 207-887. Agents Actions. 1990 Jun;30(3-4):350-62. | |||
| REF 3 | Modulation of secretory processes of phagocytes by IX 207-887. Springer Semin Immunopathol. 1993;14(4):345-52. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.